Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > New drug for cystic fibrosis does not significantly interfere with another drug that prevents organ rejection

New drug for cystic fibrosis does not significantly interfere with another drug that prevents organ rejection

Resource Type

CF Research News

Authors

Megan Smith, Kevin J Ryan, Hector Gutierrez, Luz Helena Gutierrez Sanchez, Janaina Nogueira Anderson, Edward P Acosta, Kim W Benner, Jennifer S Guimbellot

References

J Cyst Fibros. 2021 Jun 12;S1569-1993(21)00159-4. doi: 10.1016/j.jcf.2021.05.008.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR [3]
Cytochrome p450 [4]
Drug interaction [5]
Elexacaftor [6]
Ivacaftor [7]
Liver transplantation [8]
Tacrolimus [9]
Tezacaftor [10]

Date

Saturday, June 12, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [11]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/new-drug-cystic-fibrosis-does-not-significantly-interfere-another

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00158R1_FINAL_Guimbellot_240721.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34130909/ [3] https://www.ecfs.eu/research-article-keywords/cftr [4] https://www.ecfs.eu/research-article-keywords/cytochrome-p450 [5] https://www.ecfs.eu/research-article-keywords/drug-interaction [6] https://www.ecfs.eu/research-article-keywords/elexacaftor [7] https://www.ecfs.eu/research-article-keywords/ivacaftor [8] https://www.ecfs.eu/research-article-keywords/liver-transplantation [9] https://www.ecfs.eu/research-article-keywords/tacrolimus [10] https://www.ecfs.eu/research-article-keywords/tezacaftor [11] https://www.ecfs.eu/resource-guideline-type/other-guidelines